4//SEC Filing
Roberts Phil Noland 4
Accession 0001209191-23-058886
CIK 0001472012other
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 7:28 PM ET
Size
8.8 KB
Accession
0001209191-23-058886
Insider Transaction Report
Form 4
Immunome Inc.IMNM
Roberts Phil Noland
Chief Technology Officer
Transactions
- Award
Stock option (right to buy)
2023-12-13+275,000→ 275,000 totalExercise: $7.34Exp: 2033-12-12→ Common Stock (275,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the options vest on December 8, 2024, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter.
Documents
Issuer
Immunome Inc.
CIK 0001472012
Entity typeother
Related Parties
1- filerCIK 0002004455
Filing Metadata
- Form type
- 4
- Filed
- Dec 14, 7:00 PM ET
- Accepted
- Dec 15, 7:28 PM ET
- Size
- 8.8 KB